Chief Medical Officer
Dr. Galloway brings extensive experience in leadership, clinical development, medical affairs and business development. Before joining Tract, he was Senior Vice President of Clinical Development and Medical Affairs at Elevar Therapeutics. Prior to Elevar, he was Chief Medical Officer at Diffusion Pharmaceuticals and Senior Medical Director, Critical Care at La Jolla Pharmaceutical Company (acquired by Innoviva Specialty Therapeutics). Earlier in his career, he was Global Medical Director at Rakuten Medical, Director of Medical Affairs at Merck and Medical Director and Principal Investigator at DaVita Clinical Research. He has successfully overseen multiple IND, NDA and BLA submissions, engaged with global regulatory bodies and managed clinical development and medical affairs teams across a broad range of therapeutic areas, including oncology, immunology, rare disease and critical care. Dr. Galloway received his M.D. from the University of Texas Medical Branch at Galveston, completed his residency in emergency medicine at Carolinas Medical Center in Charlotte, N.C. and holds a B.A. in biology from the University of Texas at Austin.
